Literature DB >> 29900500

Structure and Function of the Human Respiratory Syncytial Virus M2-1 Protein.

Selvaraj Muniyandi1, Georgia Pangratiou1, Thomas A Edwards1, John N Barr2.   

Abstract

Human respiratory syncytial virus (HRSV) is a non-segmented negative stranded RNA virus and is recognized as the most important viral agent of lower respiratory tract infection worldwide, responsible for up to 199,000 deaths each year. The only FDA-approved regime to prevent HRSV-mediated disease is pre-exposure administration of a humanized HRSV-specific monoclonal antibody, which although being effective, is not in widespread usage due to its cost. No HRSV vaccine exists and so there remains a strong need for alternative and complementary anti-HRSV therapies. The HRSV M2-1 protein is a transcription factor and represents an attractive target for the development of antiviral compounds, based on its essential role in the viral replication cycle. To this end, a detailed analysis of M2-1 structure and functions will aid in identifying rational targets for structure-based antiviral drug design that can be developed in future translational research. Here we present an overview of the current understanding of the structure and function of HRSV M2-1, drawing on additional information derived from its structural homologues from other related viruses.

Entities:  

Keywords:  Anti-termination; Antivirals; Function; HRSV; M2–1; Structure; Transcription factor

Mesh:

Substances:

Year:  2018        PMID: 29900500     DOI: 10.1007/978-981-10-8456-0_11

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  2 in total

Review 1.  Progress in the Development of Structure-Based Vaccines.

Authors:  Sunil Thomas; Ann Abraham
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Structural Insights into the Respiratory Syncytial Virus RNA Synthesis Complexes.

Authors:  Dongdong Cao; Yunrong Gao; Bo Liang
Journal:  Viruses       Date:  2021-05-05       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.